Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
GRANT THOMAS W II
   2. Issuer Name and Ticker or Trading Symbol
LABONE INC/ [LABS] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chairman of the Board and CEO
(Last)
(First)
(Middle)
10101 RENNER BLVD.		 3. Date of Earliest Transaction (Month/Day/Year)
11/01/2005
(Street)

LENEXA, KS 66219		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/01/2005   D(1)   14,572 D $ 43.9 0 D  
Common Stock 11/01/2005   D(1)   108,005 D $ 43.9 0 I See Footnote (3)
Common Stock 11/01/2005   J(2)   1,109 D $ 43.9 0 I By 401(k) Plan

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock $ 6.9375 11/01/2005   D   20,000     (4) 02/10/2010 Common Stock 20,000 $ 36.9625 0 D  
Common Stock $ 17.8125 11/01/2005   D   75,000     (5) 05/09/2007 Common Stock 75,000 $ 26.0875 0 D  
Common Stock $ 15.9 11/01/2005   D   44,800     (6) 02/27/2012 Common Stock 44,800 $ 28 0 D  
Common Stock $ 31.65 11/01/2005   D   70,000     (7) 06/28/2014 Common Stock 70,000 $ 12.25 0 D  
Common Stock $ 24.15 11/01/2005   D   200,000     (8) 05/27/2012 Common Stock 200,000 $ 19.75 0 D  
Common Stock $ 15.4 11/01/2005   D   9,356     (9) 01/01/2012 Common Stock 9,356 $ 28.5 0 D  
Common Stock $ 17.72 11/01/2005   D   9,719     (10) 01/01/2013 Common Stock 9,719 $ 26.18 0 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
GRANT THOMAS W II
10101 RENNER BLVD.
LENEXA, KS 66219		   X     Chairman of the Board and CEO  

Signatures

 W. Thomas Grant, II by Randy Shelton attorney-in-fact   11/01/2005
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Disposition of shares in the merger between the issuer and a wholly-owned subsidiary of Quest Diagnostics Incorporated ("Merger").
(2) Disposition of shares in the Merger by the reporting person's 401(k) Plan pursuant to Rule 16b-3(c).
(3) Includes (a) 13,763 shares owned by reporting person's son, Bobby Grant, (b) 4,007 shares owned by reporting person's spouse, (c) 63,462 shares owned by reporting person's Trust, and (d) 26,773 shares owned by reporting person's 401(k) Plan.
(4) This option, which provided for vesting in five equal annual installments beginning February 10, 2001, was cancelled in the Merger in exchange for a cash payment representing the difference between the exercise price of the option and the merger consideration of $43.90 per share.
(5) This option, which provided for vesting in five equal annual installments beginning May 9, 1998, was cancelled in the Merger, in exchange for a cash payment representing the difference between the exercise price of the option and the merger consideration of $43.90 per share.
(6) This option, which provided for vesting in five equal annual installments beginning February 27, 2003, was cancelled in the Merger, in exchange for a cash payment representing the difference between the exercise price of the option and the merger consideration of $43.90 per share.
(7) This option, which provided for vesting in five equal annual installments beginning June 28, 2005, was cancelled in the Merger, in exchange for a cash payment representing the difference between the exercise price of the option and the merger consideration of $43.90 per share.
(8) This option, which provided for vesting in five equal annual installments beginning May 27, 2003, was cancelled in the Merger, in exchange for a cash payment representing the difference between the exercise price of the option and the merger consideration of $43.90 per share.
(9) This option, which provided for vesting in five equal annual installments beginning January 1, 2003, was cancelled in the Merger, in exchange for a cash payment representing the difference between the exercise price of the option and the merger consideration of $43.90 per share.
(10) This option, which provided for vesting in five equal annual installments beginning January 1, 2004, was cancelled in the Merger in exchange for a cash payment representing the difference between the exercise price of the option and the merger consideration of $43.90 per share.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.